DJknows: Otherwise I cannot understand why they ar

DJknows: Otherwise I cannot understand why they are not running with it to "break the news" or for any of them to "scoop" such an important story.

_____________________

Cyclr2R: Perhaps, because leronlimab is too good and thus is too dangerous to too many powerful interests.

———————————

CYDY has only 7 patients of full data at this point. That’s hard to sell as a definitive treatment. CNN isn’t going to break the daily scheduled program with an update on 7 patients unless the FDA gives it emergency approval first. Is that going to happen? Unlikely with only data from 7 patients.

Similar to the mTNBC BTD application, I believe NP was a little early on requesting emergency approval with only data from 7 patients. I get it, the laboratory and clinical results are promising, but’s it’s the FDA we’re talking about: they want a 390 person trial, with a placebo arm, for severely ill COVID patients. Maybe data from 25 patients would’ve been better? Maybe the prelim look at the first 50 patients in the severely ill trial will be good enough? How long will that take to get?